Nifty
Sensex
:
:
9871.50
31599.76
-1.10 (-0.01%)
-26.87 (-0.08%)

Pharmaceuticals & Drugs

Rating :
36/99

BSE: 500087 | NSE: CIPLA

579.00
1.80 (0.31%)
26-Sep-2017 | 3:59PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  • 582.00
  • 582.00
  • 570.00
  • 577.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  • 978323
  • 5664.49
  • 621.25
  • 480.20

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 46,422.30
  • 43.14
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 49,910.75
  • 0.35%
  • 3.60

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 37.29%
  • 3.17%
  • 18.03%
  • FII
  • DII
  • Others
  • 1.39%
  • 14.65%
  • 25.47%

Chart

Price | P:E | P:BV | EV:EBITDA

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 17
Jun 16
Var%
Mar 17
Mar 16
Var%
Dec 16
Dec 15
Var%
Sep 16
Sep 15
Var%
Net Sales
3,525.05
3,593.72
-1.91%
3,582.00
3,266.54
9.66%
3,647.21
3,106.55
17.40%
3,751.02
3,452.41
8.65%
Expenses
2,878.59
2,982.75
-3.49%
3,075.76
3,047.58
0.92%
2,969.56
2,652.84
11.94%
3,070.31
2,663.01
15.29%
EBITDA
646.46
610.97
5.81%
506.24
218.96
131.20%
677.65
453.71
49.36%
680.71
789.40
-13.77%
EBIDTM
18.34%
17.00%
14.13%
6.70%
18.58%
14.60%
18.15%
22.87%
Other Income
151.38
25.20
500.71%
22.79
54.74
-58.37%
153.49
79.30
93.56%
27.23
25.92
5.05%
Interest
27.86
31.34
-11.10%
33.40
36.76
-9.14%
59.33
22.95
158.52%
35.16
50.27
-30.06%
Depreciation
213.43
160.81
32.72%
632.19
141.43
347.00%
257.74
137.47
87.49%
229.18
133.96
71.08%
PBT
556.55
444.02
25.34%
-136.56
95.51
-
514.07
372.59
37.97%
443.60
631.09
-29.71%
Tax
130.77
70.81
84.68%
-75.70
-3.90
-
128.27
11.97
971.60%
71.90
181.24
-60.33%
PAT
425.78
373.21
14.09%
-60.86
99.41
-
385.80
360.62
6.98%
371.70
449.85
-17.37%
PATM
12.08%
10.39%
-1.70%
3.04%
10.58%
11.61%
9.91%
13.03%
EPS
5.08
4.54
11.89%
-0.77
1.01
-
4.66
4.27
9.13%
4.41
5.37
-17.88%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Net Sales
14,394.29
13,594.89
11,345.44
10,173.39
8,279.33
7,020.71
6,323.84
5,359.52
4,960.60
4,010.38
Net Sales Growth
5.88%
19.83%
11.52%
22.88%
17.93%
11.02%
17.99%
8.04%
23.69%
 
Cost Of Goods Sold
5,317.12
5,089.86
4,270.63
3,874.83
2,952.61
2,739.30
2,775.18
2,452.98
2,347.40
2,054.39
Gross Profit
9,077.17
8,505.03
7,074.81
6,298.56
5,326.72
4,281.41
3,548.66
2,906.54
2,613.20
1,955.99
GP Margin
63.06%
62.56%
62.36%
61.91%
64.34%
60.98%
56.12%
54.23%
52.68%
48.77%
Total Expenditure
11,918.50
11,115.22
9,183.74
8,040.34
6,081.48
5,361.86
4,954.60
4,286.56
4,215.55
3,377.91
Power & Fuel Cost
251.73
245.92
228.28
218.63
233.12
235.35
198.55
92.15
91.71
74.69
% Of Sales
1.75%
1.81%
2.01%
2.15%
2.82%
3.35%
3.14%
1.72%
1.85%
1.86%
Employee Cost
2,633.82
2,434.01
1,967.72
1,542.96
1,036.02
772.50
565.59
289.59
242.91
186.47
% Of Sales
18.30%
17.90%
17.34%
15.17%
12.51%
11.00%
8.94%
5.40%
4.90%
4.65%
Manufacturing Exp.
1,704.79
1,596.79
737.11
644.42
541.58
583.18
627.94
708.39
676.85
509.42
% Of Sales
11.84%
11.75%
6.50%
6.33%
6.54%
8.31%
9.93%
13.22%
13.64%
12.70%
General & Admin Exp.
868.31
845.89
743.46
638.08
496.81
369.85
288.71
231.05
193.89
221.14
% Of Sales
6.03%
6.22%
6.55%
6.27%
6.00%
5.27%
4.57%
4.31%
3.91%
5.51%
Selling & Distn. Exp.
1,009.21
818.76
738.87
680.32
466.22
467.61
386.67
326.48
339.15
282.21
% Of Sales
7.01%
6.02%
6.51%
6.69%
5.63%
6.66%
6.11%
6.09%
6.84%
7.04%
Miscellaneous Exp.
133.52
83.99
497.67
441.10
355.12
194.07
111.96
185.92
323.64
282.21
% Of Sales
0.93%
0.62%
4.39%
4.34%
4.29%
2.76%
1.77%
3.47%
6.52%
1.24%
EBITDA
2,475.79
2,479.67
2,161.70
2,133.05
2,197.85
1,658.85
1,369.24
1,072.96
745.05
632.47
EBITDA Margin
17.20%
18.24%
19.05%
20.97%
26.55%
23.63%
21.65%
20.02%
15.02%
15.77%
Other Income
228.69
208.21
165.55
265.37
222.14
139.52
91.68
353.50
354.49
339.28
Interest
159.38
206.63
168.29
145.74
33.91
38.34
25.10
28.30
52.23
17.52
Depreciation
1,322.93
754.22
504.71
372.64
330.48
312.22
273.33
167.07
151.79
116.26
PBT
1,222.17
1,727.03
1,654.25
1,880.04
2,055.60
1,447.81
1,162.49
1,231.09
895.52
837.97
Tax
179.76
331.59
400.03
463.38
544.31
306.51
195.22
243.50
124.50
136.93
Tax Rate
14.71%
19.20%
24.18%
24.65%
25.98%
21.17%
16.79%
18.36%
13.90%
16.34%
PAT
1,013.38
1,372.01
1,206.07
1,400.73
1,551.06
1,141.30
967.27
1,082.59
771.02
701.04
PAT before Minority Interest
1,042.41
1,395.44
1,254.22
1,416.66
1,551.06
1,141.30
967.27
1,082.59
771.02
701.04
Minority Interest
-29.03
-23.43
-48.15
-15.93
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
7.04%
10.09%
10.63%
13.77%
18.73%
16.26%
15.30%
20.20%
15.54%
17.48%
PAT Growth
-26.14%
13.76%
-13.90%
-9.69%
35.90%
17.99%
-10.65%
40.41%
9.98%
 
Unadjusted EPS
12.52
16.93
14.71
17.29
19.24
14.25
12.32
13.70
9.92
9.02

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Shareholder's Funds
12,525.42
11,516.22
10,801.49
10,050.35
9,018.68
7,638.93
6,666.13
5,910.57
4,347.80
3,755.17
Share Capital
160.90
160.68
160.59
160.58
160.58
160.58
160.58
160.58
155.46
155.46
Total Reserves
12,302.48
11,266.12
10,557.74
9,868.12
8,858.10
7,478.35
6,505.55
5,749.99
4,192.34
3,599.71
Non-Current Liabilities
4,513.35
1,407.13
2,417.66
2,028.05
1,024.96
824.27
697.34
184.22
1,104.39
689.60
Secured Loans
0.00
207.00
287.09
317.44
0.00
0.00
15.00
0.41
2.79
14.09
Unsecured Loans
3,645.36
14.88
22.19
0.43
0.55
3.25
2.92
4.66
937.45
526.36
Long Term Provisions
140.52
144.68
1,783.17
1,368.64
713.87
557.78
466.30
0.00
0.00
0.00
Current Liabilities
3,308.07
7,776.05
3,881.13
2,563.58
2,277.63
1,413.19
1,698.54
2,525.63
2,112.37
1,287.80
Trade Payables
1,571.14
1,475.82
1,452.06
979.53
828.36
691.77
720.88
805.41
757.43
533.51
Other Current Liabilities
923.79
1,006.14
654.55
408.67
250.89
489.93
235.28
192.56
255.44
337.48
Short Term Borrowings
467.23
4,969.67
1,392.48
910.47
966.38
10.20
523.06
0.00
0.00
0.00
Short Term Provisions
345.91
324.42
382.04
264.91
232.00
221.29
219.32
1,527.66
1,099.50
416.81
Total Liabilities
20,785.07
21,049.49
17,280.76
14,691.56
12,321.27
9,876.39
9,062.01
8,620.42
7,564.56
5,732.57
Net Block
9,472.00
9,368.32
6,829.64
6,496.47
3,609.97
3,215.49
3,094.18
2,011.17
1,992.49
1,661.36
Gross Block
11,305.32
10,167.62
9,561.55
8,676.27
5,317.52
4,626.35
4,240.55
2,897.26
2,693.29
2,201.79
Accumulated Depreciation
1,580.49
799.30
2,731.91
2,179.80
1,707.55
1,410.86
1,146.37
886.09
700.80
540.43
Non Current Assets
11,979.00
12,208.26
9,689.47
9,039.59
5,537.29
4,819.58
4,618.88
2,696.41
2,359.84
1,898.51
Capital Work in Progress
1,682.98
2,060.87
580.90
441.84
377.79
371.17
285.34
684.24
366.32
233.12
Non Current Investment
137.36
176.35
249.76
397.14
415.69
328.59
367.18
1.00
1.03
4.03
Long Term Loans & Adv.
477.35
426.18
1,860.78
1,552.40
978.96
865.38
841.20
0.00
0.00
0.00
Other Non Current Assets
209.31
176.54
168.39
151.74
154.88
38.95
30.98
0.00
0.00
0.00
Current Assets
8,806.07
8,841.23
7,591.29
5,651.97
6,783.98
5,056.81
4,443.13
5,924.01
5,204.72
3,834.06
Current Investments
837.39
582.34
390.02
311.43
2,116.75
940.52
223.59
245.41
79.02
89.45
Inventories
3,485.28
3,808.05
3,780.62
2,895.26
2,387.07
1,850.08
1,906.16
1,512.58
1,398.32
1,120.49
Sundry Debtors
2,497.42
2,356.27
1,997.72
1,638.89
1,668.84
1,553.58
1,490.82
1,566.63
1,852.86
1,406.49
Cash & Bank
624.21
871.40
564.26
175.76
143.01
90.46
95.97
62.06
53.39
79.70
Other Current Assets
1,361.77
437.05
145.60
35.50
468.31
622.17
726.59
2,537.33
1,821.13
1,137.93
Short Term Loans & Adv.
968.64
786.12
713.07
595.13
463.21
459.94
533.77
2,387.57
1,797.68
1,103.44
Net Current Assets
5,498.00
1,065.18
3,710.16
3,088.39
4,506.35
3,643.62
2,744.59
3,398.38
3,092.35
2,546.26
Total Assets
20,785.07
21,049.49
17,280.76
14,691.56
12,321.27
9,876.39
9,062.01
8,620.42
7,564.56
5,732.57

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Cash From Operating Activity
2,382.37
1,740.81
1,173.43
1,563.31
1,397.67
1,712.76
1,025.10
1,043.03
374.83
367.00
PBT
1,222.17
1,727.03
1,654.25
1,880.04
2,095.38
1,447.81
1,162.49
1,326.09
896.84
837.97
Adjustment
1,379.75
950.85
630.05
552.80
283.82
396.66
288.84
146.53
252.60
104.48
Changes in Working Capital
230.72
-429.38
-718.61
-561.26
-519.84
199.76
-162.03
-173.82
-708.54
-404.47
Cash after chg. in Working capital
2,832.64
2,248.50
1,565.69
1,871.58
1,859.36
2,044.23
1,289.30
1,298.80
440.90
537.98
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-450.27
-507.69
-392.26
-308.27
-461.69
-331.47
-264.20
-255.77
-64.75
-170.98
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,312.65
-4,522.63
-941.15
-1,249.86
-2,062.89
-965.10
-908.39
-562.75
-580.06
-674.41
Net Fixed Assets
-889.04
1,487.25
-534.38
-437.26
-692.52
-460.09
-601.86
-520.07
-624.70
-562.01
Net Investments
-30.10
164.99
-833.97
-985.31
-1,566.67
-464.50
-305.55
-183.78
13.43
23.05
Others
-393.51
-6,174.87
427.20
172.71
196.30
-40.51
-0.98
141.10
31.21
-135.45
Cash from Financing Activity
-1,323.85
3,104.06
164.78
-265.63
717.77
-753.17
-82.80
-471.61
178.92
254.83
Net Cash Inflow / Outflow
-254.13
322.24
397.06
47.82
52.55
-5.51
33.91
8.67
-26.31
-52.58
Opening Cash & Equivalents
858.15
545.84
175.76
143.01
90.46
95.97
62.06
53.39
79.70
132.28
Closing Cash & Equivalent
610.35
858.15
564.26
175.76
143.01
90.46
95.97
62.06
53.39
79.70

Financial Ratios

Consolidated /

Standalone
Description
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Mar 08
Book Value (Rs.)
154.92
142.23
133.38
124.79
112.21
95.03
82.91
73.50
55.82
48.20
ROA
4.98%
7.28%
7.85%
10.49%
13.97%
12.05%
10.94%
13.38%
11.60%
13.82%
ROE
8.73%
12.61%
12.10%
14.89%
18.64%
15.98%
15.40%
21.14%
19.07%
20.11%
ROCE
8.28%
13.24%
15.33%
19.05%
24.15%
19.96%
18.08%
24.22%
19.82%
22.40%
Fixed Asset Turnover
1.36
1.40
1.26
1.47
1.69
1.61
1.79
1.94
2.05
2.05
Receivable days
60.55
57.62
57.94
58.66
70.11
77.94
87.29
115.32
118.45
108.37
Inventory Days
90.98
100.43
106.36
93.68
92.19
96.16
97.61
98.17
91.54
93.41
Payable days
44.80
48.67
52.17
44.93
48.58
50.51
56.11
69.48
59.02
46.55
Cash Conversion Cycle
106.73
109.38
112.14
107.41
113.72
123.59
128.78
144.01
150.98
155.23
Total Debt/Equity
0.33
0.46
0.16
0.12
0.11
0.00
0.09
0.00
0.22
0.14
Interest Cover
8.67
9.36
10.83
13.90
62.79
38.76
47.31
47.86
18.15
48.83

News Update


  • Cipla’s arm unveils Nicotex Nicotine patches
    22nd Aug 2017, 09:36 AM

    Nicotex Nicotine patch is a skin/transdermal patch that works on the proven principle of nicotine replacement therapy and helps in quit smoking in 12 weeks

    Read More
  • Cipla - Quarterly Results
    11th Aug 2017, 12:00 AM

    Read More
  • Cipla looking to file more than 20 applications in US this fiscal
    31st Jul 2017, 09:12 AM

    The company had filed 32 ANDAs in the US in the last financial year

    Read More
  • Cipla in partnership with MMV launches quality-assured RAS
    26th Jul 2017, 08:54 AM

    RAS is a life-saving, pre-referral intervention for the management of severe malaria in young children

    Read More
  • Cipla, Novartis in talk to co-market anti-asthmatic drug Xolair in India: Report
    14th Jul 2017, 11:18 AM

    Xolair (omalizumab) is an injectable prescription medicine used to treat moderate to severe persistent asthma

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.